Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders
Status:
Completed
Trial end date:
2018-02-25
Target enrollment:
Participant gender:
Summary
This study will examine the safety and efficacy of tideglusib vs. placebo for the treatment
of core symptom domains in adolescents with Autism Spectrum Disorders
Phase:
Phase 2
Details
Lead Sponsor:
Evdokia Anagnostou
Collaborators:
Holland Bloorview Kids Rehabilitation Hospital McMaster University St. Michael's Hospital, Toronto Unity Health Toronto University of Toronto University of Western Ontario, Canada